Results 161 to 170 of about 1,396,067 (212)
Some of the next articles are maybe not open access.
Current Medicinal Chemistry, 2005
Since the discovery of the cannabinoid CB2 receptor in 1993, there has been a growing interest to clarify the importance of this G-protein coupled receptor (GPCR) for human physiology, and to investigate it as a possible target for current and future drug development.
Katri H. Raitio +4 more
semanticscholar +3 more sources
Since the discovery of the cannabinoid CB2 receptor in 1993, there has been a growing interest to clarify the importance of this G-protein coupled receptor (GPCR) for human physiology, and to investigate it as a possible target for current and future drug development.
Katri H. Raitio +4 more
semanticscholar +3 more sources
Developing the Cannabinoid Receptor 2 (CB2) Pharmacopoeia: Past, Present, and Future
Cannabinoid Receptor 2 (CB2) is a G protein-coupled receptor (GPCR) with considerable, though as yet unrealised, therapeutic potential. Promising preclinical data supports the applicability of CB2 activation in autoimmune and inflammatory diseases, pain,
Andrea J. Vernall +2 more
exaly +2 more sources
Expression of the Cannabinoid CB2 Receptor in the Rat Cerebellum: An Immunohistochemical Study
Neuroscience Letters, 2006John C Ashton +2 more
exaly +2 more sources
CB2 cannabinoid receptor mediation of antinociception
Acute Pain, 2006Management of acute pain remains a significant clinical problem. In preclinical studies, CB2 cannabinoid receptor-selective agonists inhibit nociception without producing central nervous system side effects. The CB2 receptor-selective agonist AM1241 produces antinociceptive effects that are antagonized by CB2, but not CB1, receptor-selective ...
Mohab M, Ibrahim +9 more
openaire +2 more sources
2021
CB2 receptor was once considered to be the “peripheral cannabinoid receptor.” This label was based on its discovery and abundant expression in the immune system and, until recently, absence from the central nervous system. It is now accepted that CB2 receptors are expressed in the central nervous system as well. CB2 receptors have been expressed in the
Glenn R. Rech, Samer N. Narouze
openaire +1 more source
CB2 receptor was once considered to be the “peripheral cannabinoid receptor.” This label was based on its discovery and abundant expression in the immune system and, until recently, absence from the central nervous system. It is now accepted that CB2 receptors are expressed in the central nervous system as well. CB2 receptors have been expressed in the
Glenn R. Rech, Samer N. Narouze
openaire +1 more source
Expression of CB2 cannabinoid receptor in Pichia pastoris
Protein Expression and Purification, 2002To facilitate purification and structural characterization, the CB2 cannabinoid receptor is expressed in methylotrophic yeast Pichia pastoris. The expression plasmids were constructed in which the CB2 gene is under the control of the highly inducible promoter of P. pastoris alcohol oxidase 1 gene. A c-myc epitope and a hexahistidine tag were introduced
Wenke, Feng +3 more
openaire +2 more sources
Pharmacology of cannabinoid CB1 and CB2 receptors
Pharmacology & Therapeutics, 1997There are at least two types of cannabinoid receptors, CB1 and CB2, both coupled to G-proteins. CB1 receptors are present in the central nervous system and CB1 and CB2 receptors in certain peripheral tissues. The existence of endogenous cannabinoid receptor agonists has also been demonstrated.
openaire +2 more sources
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
Gastroenterology, 2005Hepatic myofibroblasts are central for the development of liver fibrosis associated with chronic liver diseases, and blocking their accumulation may prevent fibrogenesis. Cannabinoids are the active components of marijuana and act via 2 G-protein-coupled receptors, CB1 and CB2.
Boris, Julien +8 more
openaire +2 more sources
CB2 cannabinoid receptor-mediated peripheral antinociception
Pain, 2001Cannabinoid receptor agonists diminish responses to painful stimuli. Extensive evidence implicates the CB(1) receptor in the production of antinociception. However, the capacity of CB(2) receptors, which are located outside the central nervous system (CNS), to produce antinociception is not known.
Philip T, Malan +7 more
openaire +2 more sources
CNS Effects of CB2 Cannabinoid Receptors
The Open Neuropsychopharmacology Journal, 2009Cannabinoids, endocannabinoids and marijuana use activates two well characterized cannabinoid receptors (CBRs), CB1-Rs and CB2-Rs. The expression of CB1-Rs in the brain and periphery has been well studied, but CB2-Rs have received much less attention than CB1-Rs.
Emmanuel S. Onaivi +7 more
openaire +1 more source

